Respiratory Illness season is right around the corner and experts are urging parents to take action to protect their newborns ...

GSK said on Tuesday that its Arexvy respiratory syncytial virus vaccine was 43.3% effective in preventing severe illness in ...

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...

The CDC recommends that all individuals aged 75 and older, as well as adults aged 60 and older who are at risk for severe RSV ...

The vaccine is recommended for use only in the run-up to RSV season. It's time for RSV, flu, and COVID shots, and the CDC has ...

Eligible Oxfordshire residents are being encouraged to receive their Respiratory Syncytial Virus vaccine ahead of winter.

Respiratory syncytial virus (RSV) remains the top cause of hospitalization among young children, leading to respiratory ...

RSV rates can be expected to increase, and flu, as well as other common viruses. Human metapneumovirus tends to peak in ...

In 2023, the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) recommended ...

COVID-19, influenza and RSV are the main threats between October and May. There are vaccines for all three viruses, so you ...

GSK plc (LSE/NYSE: GSK) has released new data from the AReSVi-006 Phase III trial, demonstrating the efficacy and safety of ...

In most cases, adequate hydration and over-the-counter pain relievers can help manage your symptoms during the week or two it ...